 7. On medications that increase the bleeding risk, specifically: a aspirin or another antiplatelet medication clopidogrel, prasugrel, ticlopidine, abciximab for the last 7 days prior to treatment; b oral, subcutaneous or intravenous anticoagulant medications, such as oral vitamin K inhibitors for the last 7 days, non-vitamin K inhibitor oral anticoagulant dabigatran, apixaban, rivaroxaban for the last 72 hours, and intravenous or subcutaneous heparin-derived compounds for the last 48 hours. 